Pretax income is the income that a company earns before paying income taxes. The Medicines Co's pretax income for the
three
months ended in Sep. 2019 was $-73.98 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2019 was $-241.70 Mil.
The Medicines Co's pretax margin was %.
The Medicines Co Pre-Tax Income Historical Data
The historical data trend for The Medicines Co's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Medicines Co's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, The Medicines Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Medicines Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, The Medicines Co's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where The Medicines Co's Pre-Tax Income falls into.
The Medicines Co Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
The Medicines Co's Pretax Income for the fiscal year that ended in Dec. 2018 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-241.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Medicines Co (NAS:MDCO) Pre-Tax Income Explanation
The Medicines Co's Pretax Margin for the quarter that ended in Sep. 2019 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Medicines Co Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of The Medicines Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
The Medicines Co (The Medicines Co) Business Description
The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDCO has been successfully added to your 